Fractionation of the genetic variants of human alpha 1-acid glycoprotein in the native form by chromatography on an immobilized copper(II) affinity adsorbent. Heterogeneity of the separate variants by isoelectrofocusing and by concanavalin A affinity chromatography
- PMID: 8340462
Fractionation of the genetic variants of human alpha 1-acid glycoprotein in the native form by chromatography on an immobilized copper(II) affinity adsorbent. Heterogeneity of the separate variants by isoelectrofocusing and by concanavalin A affinity chromatography
Abstract
Fractionation of the three main genetic variants (F1, S and A) of human alpha 1-acid glycoprotein (AAG), in their native (sialylated) form, by chromatography on immobilized copper(II) affinity adsorbent was investigated. This chromatographic method had been previously developed to fractionate the desialylated protein variants. For that purpose, the three main AAG phenotypes samples (F1S/A, F1/A and S/A), which had been previously isolated from individual human plasma samples, and an AAG sample from commercial source (a mixture of the phenotypes) were used in the native form. Affinity chromatography of these different samples on an iminodiacetate Sepharose-copper(II) gel at pH 7 resolved two protein peaks, irrespective of the origin of the native AAG sample used. The unbound peak 1 was found to consist of the F1, the S or both variants, depending on the phenotype of the AAG sample used in the chromatography. The bound peak 2 was found to consist of the A variant in a pure form. The fractionation results obtained with native AAG were found to be the same as those originally yielded by the desialylated protein. However, comparison of the interactions of native and desialylated AAG with immobilized copper(II) ions, using an affinity chromatographic method and a non-chromatographic equilibrium binding technique, respectively, showed that desialylation increased the non-specific interactions of the protein with immobilized copper(II) ions. The AAG variants were not fractionated when affinity chromatography was performed using immobilized zinc, nickel or cobalt(II) ions, instead of copper. After purification of each variant in the sialylated form (F1, S and A), their respective heterogeneity was studied by analytical isoelectrofocusing with carrier ampholytes in the pH range 2.5-4.5. In addition, the lectin-binding behaviour of the separate sialylated AAG variants was investigated by affinity chromatography on immobilized concanavalin A.
Similar articles
-
pH titration curves of the desialylated human alpha 1-acid glycoprotein variants by combined isoelectrofocusing-electrophoresis: utilization in the development of a fractionation method for the protein variants by chromatography on immobilized metal affinity adsorbent.J Chromatogr. 1992 May 20;577(1):43-59. doi: 10.1016/0378-4347(92)80597-j. J Chromatogr. 1992. PMID: 1400745
-
Two-step chromatographic purification of human plasma alpha(1)-acid glycoprotein: its application to the purification of rare phenotype samples of the protein and their study by chromatography on immobilized metal chelate affinity adsorbent.J Chromatogr B Biomed Appl. 1996 Mar 29;678(1):1-14. doi: 10.1016/0378-4347(95)00366-5. J Chromatogr B Biomed Appl. 1996. PMID: 8861652
-
Abnormal microheterogeneity detected in one commercial alpha 1-acid glycoprotein preparation using chromatography on immobilized metal affinity adsorbent and on hydroxyapatite.J Chromatogr B Biomed Sci Appl. 1997 Jan 10;688(1):35-46. doi: 10.1016/s0378-4347(97)88053-x. J Chromatogr B Biomed Sci Appl. 1997. PMID: 9029311
-
Changes in expression and microheterogeneity of the genetic variants of human alpha1-acid glycoprotein in malignant mesothelioma.J Chromatogr B Biomed Sci Appl. 1998 Sep 11;715(1):111-23. doi: 10.1016/s0378-4347(98)00085-1. J Chromatogr B Biomed Sci Appl. 1998. PMID: 9792503 Clinical Trial.
-
Thermodynamic approach to optimize immobilized metal affinity chromatography purification of protein C.Adv Exp Med Biol. 2006;578:173-8. doi: 10.1007/0-387-29540-2_28. Adv Exp Med Biol. 2006. PMID: 16927689 Review. No abstract available.
Cited by
-
Evidence for differences in the binding of drugs to the two main genetic variants of human alpha 1-acid glycoprotein.Br J Clin Pharmacol. 1993 Sep;36(3):241-9. doi: 10.1111/j.1365-2125.1993.tb04224.x. Br J Clin Pharmacol. 1993. PMID: 9114911 Free PMC article.
-
Structure-activity relationships for the binding of polymyxins with human α-1-acid glycoprotein.Biochem Pharmacol. 2012 Aug 1;84(3):278-91. doi: 10.1016/j.bcp.2012.05.004. Epub 2012 May 12. Biochem Pharmacol. 2012. PMID: 22587817 Free PMC article.
-
Potential Clinically Relevant Effects of Sialylation on Human Serum AAG-Drug Interactions Assessed by Isothermal Titration Calorimetry: Insight into Pharmacoglycomics?Int J Mol Sci. 2023 May 9;24(10):8472. doi: 10.3390/ijms24108472. Int J Mol Sci. 2023. PMID: 37239819 Free PMC article.
-
Biantennary glycans as well as genetic variants of alpha1-acid glycoprotein control the enantioselectivity and binding affinity of oxybutynin.Pharm Res. 2006 May;23(5):1038-42. doi: 10.1007/s11095-006-9777-8. Epub 2006 May 2. Pharm Res. 2006. PMID: 16715395
-
Development and evaluation of silica-based lectin microcolumns for glycoform analysis of alpha1-acid glycoprotein.Anal Chim Acta. 2019 Oct 31;1078:189-199. doi: 10.1016/j.aca.2019.05.060. Epub 2019 May 29. Anal Chim Acta. 2019. PMID: 31358219 Free PMC article.